Unknown

Dataset Information

0

β-Cyclodextrin⁻Hyaluronic Acid Polymer Functionalized Magnetic Graphene Oxide Nanocomposites for Targeted Photo-Chemotherapy of Tumor Cells.


ABSTRACT: A multifunctional targeted drug delivery platform (CDHA⁻MGO) has been successfully constructed by grafting β-cyclodextrin⁻hyaluronic acid polymers (CDHA) to Fe₃O₄⁻graphene oxide (MGO). The obtained CDHA⁻MGO nanocomposite has good water-dispersibility, easy magnetic separation, high near-infrared (NIR) photothermal heating, and excellent biocompatibility. The β-cyclodextrin-hyaluronic acid polymers efficaciously enhance the doxorubicin (DOX) loading amount up to 485.43 mg·g-1. Meanwhile, the Fe₃O₄⁻graphene oxide provides a facile photothermal response mechanism to handle the NIR-triggered release of DOX in weak acidic solvent environments. Significantly, the DOX-loaded nanocomposite (DOX@CDHA⁻MGO) has displayed CD44 receptor-mediated active targeting recognition and chemo-photothermal synergistic therapy of hepatoma cells. These findings suggest that the as-prepared drug delivery platform would be of valuable potential for cancer-targeted photo-chemotherapy.

SUBMITTER: Liang W 

PROVIDER: S-EPMC6401939 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

β-Cyclodextrin⁻Hyaluronic Acid Polymer Functionalized Magnetic Graphene Oxide Nanocomposites for Targeted Photo-Chemotherapy of Tumor Cells.

Liang Wenting W   Huang Yu Y   Lu Dongtao D   Ma Xuewen X   Gong Tao T   Cui Xiaodong X   Yu Baofeng B   Yang Cheng C   Dong Chuan C   Shuang Shaomin S  

Polymers 20190114 1


A multifunctional targeted drug delivery platform (CDHA⁻MGO) has been successfully constructed by grafting β-cyclodextrin⁻hyaluronic acid polymers (CDHA) to Fe₃O₄⁻graphene oxide (MGO). The obtained CDHA⁻MGO nanocomposite has good water-dispersibility, easy magnetic separation, high near-infrared (NIR) photothermal heating, and excellent biocompatibility. The β-cyclodextrin-hyaluronic acid polymers efficaciously enhance the doxorubicin (DOX) loading amount up to 485.43 mg·g<sup>-1</sup>. Meanwhil  ...[more]

Similar Datasets

| S-EPMC5503375 | biostudies-other
2022-05-10 | GSE131070 | GEO
| S-EPMC10795033 | biostudies-literature
| S-EPMC9105903 | biostudies-literature
| S-EPMC6403542 | biostudies-literature
| S-EPMC10488735 | biostudies-literature
| S-EPMC6364642 | biostudies-literature
| S-EPMC6044861 | biostudies-literature
| S-EPMC7183523 | biostudies-literature
| S-EPMC11494783 | biostudies-literature